GB Sciences, Inc. CEO Craig Ellins in High Demand as Medical Marijuana Industry Expert

        Print
| Source: GrowBlox Sciences Inc

LAS VEGAS, July 31, 2014 (GLOBE NEWSWIRE) -- GrowBLOX Sciences, Inc. (OTCQB:GBLX) a medical marijuana research and development company, announced that CEO Craig Ellins is in high demand by top tier publications, reporters, and journalists as an expert in the medical marijuana industry. Recently, several highly respected media outlets have been contacting GrowBLOX Sciences, Inc. in hopes of landing an interview with CEO Craig Ellins to discuss a variety of different topics regarding the medical marijuana industry. Some of these topics include state legislation updates, license application processes, challenges faced by medical marijuana companies, efficacy standards for medical marijuana, and how to best capitalize on the rapidly growing medical marijuana industry to name a few.

Mr. Ellins stated, "We are all very pleased to have caught the attention of so many highly respected media outlets and to be recognized as an expert in the medical marijuana industry. This interest is a testament to the quality of our science, technology, management team and our ability to continue executing our business plan."

GrowBLOX Sciences, Inc. and CEO Craig Ellins were the focal point of an article published by www.MainStreet.com titled Cannabis Dispensary in Nevada Secures Banking Account. Read the entire article here: http://www.mainstreet.com/article/small-business/cannabis-dispensary-nevada-secures-banking-account?page=1.

Craig Ellins was also recently quoted in an article by the International Business Times titled Industrial Hemp Research and Production on the Rise After New Legislation. Read the entire article here: http://www.ibtimes.com/industrial-hemp-research-production-rise-after-new-legislation-1629176.

Mr. Ellins has conducted several interviews being labeled as an industry expert in the past couple weeks which will lead to additional articles, quotes, and high quality media placements. Mr. Ellins continued, "We hope the increased media attention will not only help educate people on the exciting things happening with GrowBLOX Sciences, Inc., but increase awareness and understanding by the medical marijuana community as to what it truly means to produce a safe, consistent, and effective medicine for patients."

The Company plans to update shareholders and the investment community as several of the interviews are expected to be published within the next one to two weeks.

About GrowBLOX Sciences, Inc.

GrowBLOX Sciences, Inc., is a research and biotechnical company that has developed proprietary indoor growing chambers specifically designed for medical cannabis cultivation. The GrowBLOX chamber allows for completely controlled growing conditions, ensuring the manufacture of a consistent, toxin-free, natural and medicinal-grade product.  The Company believes that the advantages of a controlled environment over traditional outdoor or greenhouse growing, will empower the public, nutraceutical and pharmaceutical industries to embrace cannabis as an effective treatment for a myriad of serious medical conditions.  http://www.gbsciences.com

Forward-Looking Statements

Except for historical information contained herein, the statements in this release are forward-looking and made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.  Forward-looking statements are inherently unreliable and actual results may differ materially.  Examples of forward-looking statements in this news release include statements regarding the payment of dividends, marketing and distribution plans, development activities and anticipated operating results.  Factors which could cause actual results to differ materially from these forward-looking statements include such factors as the Company's ability to accomplish its business initiatives, significant fluctuations in marketing expenses and ability to achieve and expand significant levels of revenues, or recognize net income, from the sale of its products and services, as well as the introduction of competing products, or management's ability to attract and maintain qualified personnel necessary for the development and commercialization of its planned products, and other information that may be detailed from time to time in the Company's filings with the United States Securities and Exchange Commission.  The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Jonathan Barkman
Riverview Capital Enterprises
+1-866-845-0105